Preoperative Low Prealbumin Is Associated With Recurrence in Patients With Stage II/III Gastric Cancer After Laparoscopic D2 Gastrectomy

被引:7
|
作者
Gao, Chun [1 ]
Zeng, Ci Dian Dan [1 ]
Tong, Yi Xin [1 ]
Zhu, Li [1 ]
Zhang, Sheng [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
gastric cancer; recurrence; risk factor; prealbumin; recurrence-free survival; cancer; PROGNOSTIC NUTRITIONAL INDEX; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; METASTASES; INDICATOR; SURVIVAL; COMPLICATIONS; CARCINOMA; JAPANESE; SURGERY;
D O I
10.3389/fsurg.2022.819514
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPostoperative recurrence is associated with poor prognosis in patients with gastric cancer. This study aimed to explore predictive factors contributing to recurrence in patients with stage II/III gastric cancer after laparoscopic D2 gastrectomy. MethodsThis retrospective study was conducted at a single tertiary referral hospital. Patients diagnosed with gastric cancer who met the inclusion criteria were included in the study. The clinicopathological characteristics of the patients were collected. The patients were divided into recurrence and non-recurrence groups. The predictive factors were investigated using univariate and multivariate analyses. ResultsIn total, 462 patients were included. The incidence of recurrence was 26.4% (122/462) in all patients. The most common recurrence pattern was haematogenous recurrence. In the multivariate analysis, the independent predictive factors for recurrence were serum prealbumin level (p < 0.001), prognostic nutritional index (p = 0.001), carbohydrate antigen 19-9 (CA19-9) (p < 0.001), number of lymph node metastases (p < 0.001), signet-ring cell carcinoma (p = 0.001), tumor deposit (p = 0.001), and no/incomplete adjuvant chemotherapy (p < 0.001). ConclusionsOur findings revealed that nutritional status was an independent predictive factor for recurrence in patients with gastric cancer after D2 gastrectomy. We suggest that patients with risk factors for recurrence receive both nutritional support and intense surveillance.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer
    Serrano, Mariana
    Araujo, Jhajaira M.
    Pacheco, Cristian
    Macetas, Jackeline
    Blum, Mariella A.
    Carrato, Alfredo
    Ruiz, Eloy
    Berrospi, Francisco
    Luque, Carlos
    Chavez, Ivan
    Payet, Eduardo
    Taxa, Luis
    Montenegro, Paola
    ECANCERMEDICALSCIENCE, 2022, 16
  • [2] Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy
    Kawamura, Yuichiro
    Satoh, Seiji
    Umeki, Yusuke
    Ishida, Yoshinori
    Suda, Koichi
    Uyama, Ichiro
    SPRINGERPLUS, 2016, 5
  • [3] Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
    Deng, Zi-Jian
    Nie, Run-Cong
    Lu, Jun
    Chen, Xi-Jie
    Xiang, Jun
    Huang, Chang-Ming
    Chen, Ying-Bo
    Peng, Jun-Sheng
    Chen, Shi
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [4] Postoperative Chemoradiotherapy for Advanced Gastric Cancer after D2 Gastrectomy
    Deng, Xia
    Jin, Xiance
    Xue, Shengliu
    Zhang, Xuebang
    Su, Huafang
    Zhang, Ping
    Xie, Congying
    HEPATO-GASTROENTEROLOGY, 2014, 61 (133) : 1472 - 1477
  • [5] Comparison of SOX and CAPOX in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: A randomized controlled trial
    Liu, Xin
    Yan, Yongjia
    Lu, Li
    Liu, Yang
    Ma, Jun
    Wang, Xi
    Wang, Daohan
    Liu, Bang
    Liu, Zhuo
    Zhou, Xueying
    Cui, He
    Zhao, Zhicheng
    Li, Chuan
    Liu, Jian
    Li, Weidong
    Huang, Qing-Xing
    Zhao, Qun
    Liu, Tong
    Fu, Weihua
    CANCER MEDICINE, 2024, 13 (11):
  • [6] Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy
    Toru Aoyama
    Takaki Yoshikawa
    Tsutomu Hayashi
    Hiroshi Kuwabara
    Yo Mikayama
    Takashi Ogata
    Haruhiko Cho
    Akira Tsuburaya
    Annals of Surgical Oncology, 2012, 19 : 1568 - 1574
  • [7] Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
    Liang, Yanrui
    Zhao, Liying
    Chen, Hao
    Lin, Tian
    Chen, Tao
    Zhao, Mingli
    Hu, Yanfeng
    Yu, Jiang
    Liu, Hao
    Li, Guoxin
    BMC CANCER, 2021, 21 (01)
  • [8] Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
    Zheng, Xiaohao
    Wu, Yunzi
    Zheng, Li
    Xue, Liyan
    Jiang, Zhichao
    Wang, Chenfeng
    Xie, Yibin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2
    Li, Yi-Fan
    Zhang, Wen-Bing
    Gao, Yu-Ye
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 15 (01): : 32 - 48
  • [10] Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy
    Aoyama, Toru
    Yoshikawa, Takaki
    Hayashi, Tsutomu
    Kuwabara, Hiroshi
    Mikayama, Yo
    Ogata, Takashi
    Cho, Haruhiko
    Tsuburaya, Akira
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) : 1568 - 1574